Optical Express Group claims good patient outcomes

Article

Recent research by the Optical Express Group says it has revealed that of 32,000 clients surveyed following treatment in 2009, 89 per cent achieved 20/16 vision or better.

Recent research by the Optical Express Group says it has revealed that of 32,000 clients surveyed following treatment in 2009, 89 per cent achieved 20/16 vision or better. The business has also recently made a $12 million investment installing iFS 150 femtosecond laser systems in all its 44 treatment clinics in the UK.

Commenting on the trend towards better than 20/20 outcomes Dr Steve Schallhorn, Medical Director and Chair of the International Medical Advisory Board for Optical Express said: “What we have reported is that our highly skilled surgeons using the very latest advancements in LASIK technology, consistently results in most patients achieving better than 20/20 unaided vision. These outcomes are phenomenal and testament to the medical and surgical care provided by Optical Express. It is also setting a new world-wide standard for laser eye surgery procedure outcomes.

“From a very early stage, Optical Express decided to lead from the front by advancing the frontiers of laser eye surgery. Together with the greatest experience in ophthalmology, our International Medical Advisory Board is second to none and is driving up standards to deliver safe and effective eye surgery with high levels of patient satisfaction.

“We continue to have very high levels of satisfaction among our patients. This is evidenced through our growth over the last year, during a time of deep economic turmoil.”

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.